Ausgabe Sonderheft 1/2013
7th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
Inhalt (269 Artikel)
OR2-001 – The possible role of pyrin on cell migration
B Peynircioğlu, ZY Akkaya, C Guler, A Cetinkaya, ZE Taskiran, E Yilmaz
OR2-002 – The risk of FMF in MEFV heterozygotes
I Jéru, V Hentgen, E Cochet, P Duquesnoy, G Le Borgne, E Grimprel, K Stankovic Stojanovic, S Karabina, G Grateau, S Amselem
OR3-001 – RIP2 kinase is activated in Blau Syndrome and IBD
KP Foley, B Desai, A Vossenkämper, MA Reilly, P Biancheri, L Wang, DB Lipshutz, J Connor, M Miller, PA Haile, LN Casillas, BJ Votta, PJ Gough, TT MacDonald, CH Wouters, CD Rosé, J Bertin
OR3-002 – Blau Syndrome cohort study: ocular outcome
CD Rose, R Cimaz, C Thomee, R Khubchandani, G Espada, R Russo, M Harjacek, B Bader-Meunier, P Brissaud, N Wulffraat, S Vastert, R Merino, A Naranjo-Hernandez, S Oliveira Knupp, F Mackenson, J Arostegui, J Anton Lopez, J Fernandez-Martin, C Wouters
P01-001 – Musculoskeletal sonography in FMF patients
O Karadag, S Yilmaz, V Yazisiz, M Cinar, H Erdem, S Pay, A Dinc
P01-002 – Comparison between different colchicines responders
ZB Özçakar, AH Elhan, F Yalcinkaya
P01-003 – Bleeding disorder in FMF
O Karadag, T Akin Telli, N Sayinalp, I Ertenli
P01-004 – MEFV genes and FMF
F Salehzadeh, M Jafariasl, S Jahangiri, S Hosseiniasl
P01-005 – Idiopathic uveitis and FMF
F Salehzadeh, O Yasrebi, S Jahangiri, S Hosseiniasl
P01-006 – MEFV mutation detection in Arabic patients
R Taha, S Ayesh, M Kambouris, H El-Shanti
P01-007 – Evaluation of potential risk factors of Amyloidosis
T Kasifoglu, S Bilge, E Gonullu, F Bekdemir, C Korkmaz
P01-008 – FMF genotype-phenotype correlations in Germany
M Jeske, P Lohse, T Kallinich, T Berger, C Rietschel, D Holzinger, C Kamlah, P Lankisch, R Berendes, G Dückers, G Horneff, E Lilienthal, JP Haas, A Giese, F Dressler, J Berrang, C Pütter, L Braunewell, U Neudorf, T Niehues, E Lainka
P01-009 – 2 years of colchicine IV in intractable FMF
L Kaly, N Boulman, D Rimar, G Slobodin, I Rosner, M Rozenbaum
P01-010 – Anti-TNF agents in intractable FMF: four cases
L Kaly, D Rimar, G Slobodin, N Jiries, I Rosner, M Rozenbaum
P01-011 – Colchicine compliance and amyloidosis
H Ozdogan, S Ugurlu, G Hatemi
P01-012 – Evaluation of autonomic function in FMF
N Aktay Ayaz, N Melikoğlu Kiplapinar, G Keskindemirci, G Aydogan, O Isal Tosun, A Guzeltas, E Odemis
P01-013 – Cochlear involvement in FMF
N Aktay Ayaz, G Keskindemirci, A Batıoglu, G Aydogan, E Aldemir, Z Donmez, O Yigit, A Akçay, S Ozen
P01-014 – Subclinical atherosclerosis in FMF
S Ugurlu, SN Karaca, Y Demirel, E Seyahi
P01-015 – Effect of Cochicine on cholesterol in FMF and BS
S Ugurlu, E Seyahi, I Hanci, SM Pehlevan, H Ozdogan, H Yazici
P01-016 – Decreased vitamin D levels in FMF patients
H Onur, H Aral, V Arıca, G Bercem, M Usta, Ö Kasapçopur
P01-017 – FMF presention with features of malignancy
N Aktay Ayaz, G Keskindemirci, D Tugcu, A Akçay, E Aldemir, G Aydogan
P01-018 – An earliest diagnosis of FMF
N Aktay Ayaz, E Aldemir, G Keskindemirci, C Aydogmus, G Aydogan, S Kavuncuoglu
P01-019 – Anti-CCP antibodies are not associated with FMF
H Onur, H Aral, V Arıca, G Bercem, M Usta, Ö Kasapçopur
P01-020 – Starting time of inflammatory attacks in patients
F Berktaş, N Alpay, B Toz, OK Bakkaloğlu, B Erer, A Gül
P01-021 – Macrophage migration inhibitory factory in FMF
I Sari, Y Savran, DL Kozaci, N Gunay, F Onen, S Akar
P01-022 – MEFV gene mutations registered to infevers
A Berdeli, S Nalbantoglu, D Tigli, I Demirel, M Atan
P01-024 – Vascular risk assessment and MMP-3 gene in FMF
S Mir, B Sozeri, K Ozdemir, A Berdeli
P01-025 – Decreased vitamin D levels in children with FMF
B Makay, A Anık, G Çatlı, A Abacı, T Küme, E Böber, E Ünsal
P01-026 – A case of FMF and hereditary coproporphyria
A Ganesha, S Savic
P01-027 – Normal HRV in colchicine-resistant FMF patients
U Nussinovitch, A Livneh
P01-028 – MEFV mutation in Morrocan child wuth familial Mediterranean fever
B Chkirate, A Dibi, A Bentahila
P01-029 – Microscopic hematuria in FMF
L Grabowitz, OL Kukuy, M Lidar, I Ben Zvi, O Feld, Y Kesel, A Livneh
P01-030 – Proteinuria in FMF – prediction of nephropathy type
OL Kukuy, A Livneh, A Ben-David, J Kopolovic, A Volkov, Y Shinar, E Holtzman, D Dinour, I Ben-Zvi
P01-031 – Anakinra for colchicine resistant FMF
I Ben-Zvi, OL Kukuy, M Lidar, O Feld, O Perski, S Kivity, P Langevitz, B Pistrom, A Livneh
P01-032 – Characterization of genetic-negative FMF
I Ben-Zvi, C Herskovizh, Y Kassel, A Livneh
P01-033 – Co-occurance of Crohn’s disease and FMF
A Epstein, I Ben-Zvi, Y Shinar, M Lidar, S Ben-Horin, A Livneh
P01-034 – Cancer in FMF: a population based study Israel
R Brenner, S Kivity, Y Shinar, I liphshitz, E Ben-Chetrit, A Livneh, B Zvi
P01-035 – Long-term IV colchicine in oral colchicines failure
O Feld, I Ben Zvi, OL Kukuy, A Livneh
P01-036 – Systemic amyloidosis presenting with amyloidoma
H Nalcacioglu, G Genc, S Ayyildiz, M Kefeli, O Aydin, M Elli, M Ceyhan, O Ozkaya
P01-037 – Genetic analysis practice prior to FMF diagnosis
Y Shinar, Y Berkun, A Livneh, S Padeh
P01-038 – QT and JT dispersion in children with FMF
K Fidanci, A Kilic, M Gulgun, C Acikel, G Basbozkurt, E Demirkaya, F Gok
P01-039 – Autonomic functions in children with FMF
K Fidanci, M Gulgun, A Kilic, C Acikel, E Demirkaya, S Ozen, F Gok
P01-041 – Patient management and rare FMF symptoms
MM Moradian, H Hayrapetyan, G Amaryan, A Yeghiazaryan, T Sarkisian
P01-042 – Joint involvement in Armenian children with FMF
G Amaryan, G Khloyan, R Davtyan, T Sarkissian, A Tadevosyan
P01-043 – Comparative characteristic of FMF and FMF with HSP
H Sargsyan, P Ghazaryan
P01-044 – Uncommon manifestations of familial Mediterranean
A Beglaryan, K Ginosyan, A Ayvazyan
P01-045 – Epilepsy in Armenian children with FMF
N Mkrtchyan, G Amaryan, N Aghababyan, K Mirzabekyan, T Sarkissian
P01-046 – Membrane aspects of Hemostasis disorders at ATYPIC
P Ghazaryan, A Zakharyan, N Mkrtchyan
P01-047 – PH with right-sided heart failure in FMF
AV Sargsyan, MZ Narimanyan
P01-048 – Systemic onset JIA with coronary artery dilation
N Aktay Ayaz, G Keskindemirci, E Aldemir, N Melikoğlu Kiplapinar, G Aydogan
P01-049 – Assessment of vascular function in systemic JIA
B Sozeri, K Ozdemir, S Mir
P01-050 – Anakinra in systemic JIA: single center experience
M Pardeo, A Insalaco, C Bracaglia, R Nicolai, AE Tozzi, G Prencipe, F De Benedetti
PW01-001 – Pyrin-PSTPIP1 relation during cell migration
ZY Akkaya, B Balci-Peynircioglu, A Cetinkaya, N Purali, E Yilmaz
PW01-002 – Colchicine resistant FMF in Turkish children
FK Kara Eroglu, Y Bilginer, F Ozaltin, R Topaloglu, S Ozen
PW01-003 – Frequency of MEFV mutations in Turkish population
F Yalcinkaya, A Duzova, S Gonen, B Ozcakar, E Baskin, O Ozkaya, O Soylemezoglu
PW01-004 – The sequence analysis in E148Q homozygous patients
R Topaloglu, C Yildiz, E Taskiran, E Korkmaz, N Besbas, S Ozen, A Duzova, N Akarsu, F Ozaltin
PW01-005 – Effects of placebo and colchicine on FMF patients
F Özaltın, Y Bilginer, B Gülhan, I Bajin, Ö Erdoğan, S Özen
PW01-006 – The effect of colchicine on physical growth in FMF
N Cakar, TC Yoldas, B Acar, N Uncu, S Cayci
PW01-007 – Colchicine brand switching in FMF patients
J Jagger, J McGonagle
PW01-008 – The inflammasome and secretory pathways in FMF
B Orak, T Kallinich, M Lieber, H von Bernuth, H Wittkowski, D Foell
PW01-009 – Markers of inflammation in adult FMF patients
A Giese, H Wittkowski, A Örnek, M Kurucay, E Lainka, BF Henning
PW01-010 – The effect of pregnancy on disease course in FMF
T Eviatar, N Zaks, OL Kukuy, A Livneh, M Lidar
PW01-011 – Exertional leg pain and spondyloarthropathy on FMF
Y Rosman, I Eshed, A Livneh, M Lidar
PW01-012 – Canakinumab in patients with FMF
S Ugurlu, E Seyahi, G Hatemi, A Hacioglu, H Ozdogan
PW01-013 – Localization of alternative pyrin isoforms
E Tahir Turanli, S Erdemir, G Celikyapi Erdem
PW01-014 – MEFV methylation analysis in FMF and JRA diseases
E Tahir Turanli, AK Kirectepe, Ö Kasapçopur
PW01-015 – Canakinumab in adults with colchicin resistant FMF
A Gül, H Özdoğan, Ö Kasapçopur, B Erer, S Uğurlu, N Davis, S Sevgi
PW01-016 – Are different disease subtypes present in FMF
S Akar, T Kasifoglu, D Solmaz, S Bilge, I Sari, M Tunca
PW01-017 – Urine MMP-3 level as a biomarker for in FMF attack
B Sozeri, N Dincel, E Yilmaz, S Mir
PW01-018 – Circulating endothelial biomarkers in FMF
I Sari, BO Pamuk, S Selcuk, G Gokce, DL Kozaci
PW01-019 – MEFV gene mutations in 53 periodic fever patients
N Toplak, M Debeljak, T Avcin
PW01-020 – MEFV mutations carrier rate in Central Europe
M Debeljak, N Toplak, N Abazi, M Kolnik, B Szabados, V Mulaosmanovic, J Radović, J Vojnović, T Constantin, D Kuzmanovska, T Avčin
PW01-021 – The phenotype of FMF due to deletion M694
HJ Lachmann, DM Rowczenio, JA Gilbertson, JD Gillmore, AD Wechalekar, T Lane, PN Hawkins
PW01-022 – Dissociation between CRP and SAA in FMF
K Stankovic Stojanovic, V Hentgen, S Georgin-Lavialle, S Fellahi, I Jeru, S Amselem, J-P Bastard, G Grateau
PW01-023 – Ex vivo PBMC cytokine profile in FMF patients
JN Ibrahim, R Jounblat, A Delwail, J Abou-Ghoch, N Salem, E Chouery, A Megarbane, J-C Lecron, M Medlej-Hashim
PW01-024 – Phenotypic analysis of a MEFV negative FMF cohort
A Soriano, D Rigante, L Cerrito, C Fonnesu, L Sicignano, A Gallegos, R Manna
PW01-025 – Definition of colchicine resistance in FMF
E Demirkaya, C Acikel, A Tufan, A Kucuk, A Berdeli, A Gul, AM Onat, A Delibas, A Duzova, A Dinc, O Yavascan, O Kasapcopur, B Makay, B Goker, B Sozeri, B Kisacik, E Comak, E Unsal, E Erken, E Gunal, E Baskin, F Yalcinkaya, F Yildiz, F Gok, G Basbozkurt, G Ozcelik, G Demircin, H Poyrazoglu, H Erdem, H Direskeneli, H Ozer, H Ozdogan, I Simsek, I Dursun, I Gokce, M Tunca, M Gurgoze, N Cakar, N Akinci, N Ayaz, O Donmez, O Ozkaya, R Topaloglu, S Kavukcu, S Yuksel, S Akar, S Bakkaloglu, S Emre, S Senel, S Erten, S Yavuz, S Kalman, T Kasifoglu, U Kalyoncu, Y Tabel, Z Ekinci, S Ozen
PW01-026 – Validation of pediatric diagnostic criteria in FMF
E Demirkaya, S Ozen, C Saglam, T Turker, A Duzova, P Woo, I Konè-Paut, M Doglio, G Amaryan, J Frenkel, Y Uziel, A Insalaco, L Cantarini, M Hofer, S Boiu, C Modesto, A Bryant, D Rigante, E Papadopoulou-Alataki, S Guillaume-Czitrom, N Ruperto, M Gattorno
PW01-027 – Predictors and survival of FMF related amyloidosis
E Demirkaya, I Yilmaz, C Acikel, M Saglam, H Unal, M Gok, A Polat, H Cetinkaya, T Eyileten, S Sari, AO Yildirim, Y Oguz, A Vural, JJ Carrero
PW01-028 – Developing a new severity score for FMF
E Demirkaya, C Acikel, A Gul, M Gattorno, E Ben-Chetrit, H Ozdogan, P Hashkes, A Polat, O Karadag, A Livneh, S Ozen
PW01-029 – Relationship between apoptotic alterations and inflammation in familial Mediterranean fever
G Mkrtchyan, A Boyajyan
PW01-030 – Pulmonary manifestations of FMF
AV Sargsyan, AR Davtyan, YS Sargsyan
PW01-032 – FMF-like state: genetic factors unrelated to MEFV
D Babikyan, I Jeru, B Copin, H Hayrapetyan, S Amselem, T Sarkisian
PW01-033 – Phenotype – genotype in Armenian children with FMF
G Amaryan, T Sarkissian, T Sarkissian, H Hayrapetyan, H Hayrapetyan, A Tadevosyan, A Tadevosyan
PW01-034 – Clinical-genetic investigation of FMF in Armenia
H Hayrapetyan, G Amaryan, A Yeghiazaryan, T Sarkisian
PW01-035 – Mutations in PB30.2D and complexing with caspase-1
K Nazaryan, G Arakelov
PW01-036 – Renal replacement therapy in patients with FMF
M Papazyan, M Voskanyan, H Nazaryan, S Babloyan, A Sarkissian
PW01-037 – Amyloidosis probability depending on MEFV type
A Simonyan, A Ayvazyan, V Vardanyan, L Kozlovskaya, V Rameev
PW01-038 – Genomewide association study of Still’s disease
MJ Ombrello, EF Remmers, E Zeggini, W Thomson, DL Kastner, P Woo
PW01-039 – Long-term efficacy of anakinra in SoJIA patients
A Naselli, J Tibaldi, A Accogli, A Buoncompagni, S Viola, S Signa, P Picco, A Ravelli, A Martini, M Gattorno
PW01-040 – Definition of polymorphism C3435T MDR1 gene in JIA
F Rokhlina, G Novik
OR5-001 – Characterization of tonsil infiltration in PFAPA
S Chiesa, R Caorsi, F Penco, A Bertoni, S Borghini, A Sementa, A Omenetti, F Bellora, R D'Agostino, A Martini, M Gattorno
OR5-002 – In vitro studies in Schnitzler’s syndrome
HD De Koning, J Schalkwijk, J Jongekrijg, IM van Vlijmen-Willems, D Rodijk-Olthuis, M Stoffels, JW van der Meer, PL Zeeuwen, A Simon
OR6-001 - S100A12 as pro-inflammatory TLR4 ligand
C Kessel, H Wittkowski, A Lüken, T Weinhage, G Varga, T Vogl, T Wirth, D Viemann, P Björk, M van Zoelen, F Gohar, G Srikrishna, J Roth, D Foell
OR6-002 – Thromboembolism in autoinflammatory syndromes
PM Vaitla, R Weldon, I Tynan, EM McDermott, E Drewe
OR6-003 – Prospective evaluation of PFAPA patients
I Bosio, A Meini, P Cancarini, M Berlucchi, G Savoldi, M Cattalini
OR6-004 – MRP8/14 promote MSU-crystal induced inflammation
D Holzinger, N Nippe, T Vogl, K Marketon, V Mysore, T Weinhage, N Dalbeth, B Pool, T Merriman, D Baeten, A Ives, N Bagnoud, N Busso, D Foell, S Bas, C Gabay, J Roth
OR6-005 – Cystine crystals activate inflammasomes
G Prencipe, I Caiello, S Petrini, L Bracci Laudiero, F Emma, F De Benedetti
OR6-006 – IL36RN alleles in skin auto-inflammation
F Capon, N Setta-Kaffetzi, D Berki, S Mahil, A Navarini, VM Patel, C Siew-Eng, AD Burden, C Griffiths, M Seyger, R Trembath, C Smith, J Barker
OR7-001 – By chip pyrin binds the IRF2 promoter
G Wood, Y Kanno, J Balow Jr, H-W Sun, I Aksentijevich, DL Kastner
OR7-002 – Pyrin 577 mutations in dominant autoinflammation
M Stoffels, A Szperl, A Simon, MG Netea, TS Plantinga, M van Deuren, S Kamphuis, H Lachmann, E Cuppen, WP Kloosterman, J Frenkel, CC van Diemen, C Wijmenga, M van Gijn, JW van der Meer
OR7-003 – MEFV genotype, IL1B and role of NLRP3 in FMF
A Omenetti, S Carta, L Delfino, A Martini, M Gattorno, A Rubartelli
OR7-004 – Validation of AIDAI score
M Piram, I Koné-Paut, M Gattorno, N Ruperto
OR7-005 – Canakinumab in childhood colchicine resistant FMF
PJ Hashkes, Y Butbul Aviel, S Lubin, L Tseng, E Ben Dayan, T Rachmilewitz, R Brik
OR7-006 – Autophagy as a player in inflammation in TRAPS
T Bachetti, S Chiesa, P Castagnola, D Bani, E Di Zanni, A Omenetti, A D'Osualdo, A Fraldi, A Ballabio, R Ravazzolo, A Martini, M Gattorno, I Ceccherini
P02-001 – A novel TNFRSF1A mutation in periodic fever
E Erken, F Yıldız, D Arslan Taş, S Dinkci
P02-002 - IL36RN mutations in patients with DITRA
JI Arostegui, MA Vicente-Villa, A Chaves, E Gonzalez-Roca, E Ruiz-Ortiz, J Rius, S Plaza, MA Gonzalez-Enseñat, J Yague
P02-003 - HIDS in a consanguineous family form Saudi Arabia?
Q Zhou, R Sleiman, DL Kastner, I Aksentijevich
P02-004 - AIDs in a registry of children in North America
JS Hausmann, CM Biggs, D Goldsmith, F Dedeoglu
P02-005 - Overlap of FMF and HIDS in one Arabic family
T Moussa, B Aladbe, A Aly, R Taha, H El-Shanti, B Fathalla
P02-006 - A novel PSTPIP1 mutation in PAPA syndrome
B Fathalla, M Al-Mutawa, F Al-Amri, S Al-Dosari, M Kambouris, H El-Shanti
P02-007 - Childhood autoinflammatory disorders in Qatar
B Aladbe, A Aly, R Taha, H Elshanti, T Moussa, F Al Amry, B Fathalla
P02-009 - Candle syndrome: expanding spectrum
I Kone-Paut, A Kinoshita, H Ida, D Roybet, C Leaute-Labreze, P Pillet
P02-010 - A novel 24 nucleotide deletion in the TNFRSF1A
DM Rowczenio, H Trojer, G Wang, PN Hawkins, HJ Lachmann, NM Stewart
P02-011 - TRAPS syndrome debuted as systemic JIA
T Sleptsova, E Alexeeva, E Mitenko, S Valieva, T Bzarova, R Denisova, K Isaeva
P02-012 - HAIDS in practice of Russian rheumatologist
E Fedorov, S Salugina, N Kuzmina
P02-013 - TH17 cells and regulatory T cells in TRAPS
PM Vaitla, E Drewe, EM McDermott, I Todd, L Fairclough
P02-014 - Consequences of Arginine 92 mutations in TNFR1
I Jéru, S Charmion, E Cochet, B Copin, G Le Borgne, P Cathebras, J Gaillat, P Duquesnoy, S Karabina, V Hentgen, S Amselem
P02-015 - A novel MVK mutation in a child with AA amyloid
A Kolsky, D Rowczenio, H Lachmann, Z Vernerova, F Votava, P Dolezalova
P02-016 - A novel PSMB8 mutation causing candle syndrome
V Messia, M Pardeo, R Nicolai, C Bracaglia, F De Benedetti, A Insalaco
P02-017 - Periodic fever syndrome masquerading as eczema…
TV Nguyen, J Sugarman, K Leslie
P02-018 - PSTPIP1 gene mutations in periodic fever patients
K Takabe, Y Adachi, H Saito, T Yamashita, Y Wakai, K Saito, Y Shinohara
P02-019 - Detection of risk factors for AA-amyloidosis
S Németh, L Obici, S Grandemange, H Lachmann, C Oberkanins
P02-020 - CAPS in Turkish children: treatment with ANTI IL1
FK Kara Eroglu, N Besbas, F Ozaltin, Y Bilginer, A Duzova, S Ozen
P02-021 - Atypical CAPS consequence of novel NLPR3 mutations
E Gonzalez-Roca, G Espinosa, J Bartra, E Ruiz-Ortiz, J Rius, S Plaza, J Yague, JI Arostegui
P02-022 - Atypical cryopirin associated periodic syndrome
S Bujan Rivas, JI Arostegui Gorospe, A Sellas Fernandez, CP Simeon Aznar, J Aguilar Company, J Ordi Ros, M Vilardell Tarres
P02-023 - NLRP3 mosaicism as a cause of late-onset CAPS
Q Zhou, AK Ombrello, D Chin, DL Kastner, I Aksentijevich
P02-024 - Clinical impact of V198M mutation in NLRP3 gene
R Caorsi, A Insalaco, L Obici, L Cantarini, A Meini, M Alessio, L Lepore, F Zulian, F Caroli, I Ceccherini, A Martini, M Gattorno
P02-025 - Homozygous Q705K sequence variant in NLRP3
S Berg, M Sundqvist, K Christenson, A Welin, H Björnsdottir, J Bylund, P Wekell, P Söderkvist, A Karlsson
P02-026 - Model-based characterization of the PKPD relationship for canakinumab in CAPS: a step towards personalized
A Gautier, P Lowe, A Skerjanec, P McKernan, O Luttringer, M Fink
P02-027 - Quality of life in CAPS treated by Canakinumab
C Marsaud, I Marie, I Koné-Paut
P02-028 - Muckle-Wells syndrome and renal transplantation
B Kortus-Götze, J Hoyer
P02-029 - CAPS or SJIA
E Alekseeva, R Denisova, S Valieva, T Bzarova, T Sleptsova, E Mitenko, K Isayeva
P02-030 - Unusual CNS manifestation
E Schuh, P Lohse, I Meinl, T Kümpfel
P02-031 - Phenotype of V198M and Q703K NLRP3 variants
V Messia, M Pardeo, R Nicolai, C Bracaglia, F De Benedetti, A Insalaco
P02-032 - CAPS: a novel mutation and an unusual phenotype
A Insalaco, PS Buonuomo, C Bracaglia, M Pardeo, I Ceccherini, R Nicolai, F De Benedetti
P02-033 - CAPS diagnosis and treatment in an Israeli family
Y Shinar, G Breuer, A Livneh, P Hashkes
PW02-001 - Exome sequencing for autoinflammatory disorders
SE Boyden, Q Zhou, I Aksentijevich, DL Kastner
PW02-002 - Single MVK mutation and recurrent fevers
K Barron, A Ombrello, D Goldsmith, I Aksentijevich, A Jones, D Kastner
PW02-003 - Efficacy of anakinra in etanercept-resistant TRAPS
AK Ombrello, PM Hoffmann, A Jones, KS Barron, DL Kastner
PW02-004 - Autoinflammatory syndromes: a clinical review
CM Biggs, JS Hausmann, S Kim, E Janssen, P Nigrovic, R Fuhlbrigge, R Sundel, F Dedeoglu
PW02-005 - A web registry of genotype-phenotype correlation
M Doglio, R Papa, R Caorsi, S Federici, M Finetti, A Naselli, N Ruperto, A Martini, I Ceccherini, M Gattorno
PW02-006 - PAPA syndrome clinical spectrum and IL1B release
A Omenetti, R Caorsi, S Carta, L Delfino, A Martini, A Rubartelli, M Gattorno
PW02-007 - The Eurofever registry: 3 years of enrollment
S Federici, J Frenkel, S Ozen, A Jordi, JI Arostegui, F De Benedetti, P Dolezalova, H Girschick, V Hentgen, M Hofer, H Lachmann, I Koné-Paut, J Kuemmerle-Deschner, B Neven, H Ozdogan, C Rose, A Simon, S Stojanov, N Toplak, I Touitou, R Vesely, P Woo, C Wouters, N Ruperto, A Martini, M Gattorno
PW02-008 - TRAPS in the real world: an international registry
HJ Lachmann, R Papa, K Minden, L Obici, L Cantarini, J Frenkel, J Anton, I Koné-Paut, M Cattalini, B Bader-Meunier, N Ruperto, A Martini, I Touitou, P Woo, M Gattorno
PW02-009 - PAPA syndrome: results from the Euroefever registry
R Caorsi, A Insalaco, D Marotto, J Frenkel, A Martini, F De Benedetti, M Gattorno
PW02-010 - The diagnostic challenge of bone lesions in AID
R Caorsi, P Picco, A Buoncompagni, S Signa, F Minoia, S Federici, A Martini, M Gattorno
PW02-011 - Favorable response to anakinra in aisle patients
H Ozdogan, M Gattorno, S Ugurlu, M Di Rocco, G Hatemi, D Ustek, A Gul
PW02-012 - First clinical description of an infant with DITRA
L Rossi-Semerano, M Piram, C Chiaverini, D De Ricaud, A Smahi, I Koné-Paut
PW02-013 - The role of IL6 and LPS in pathogenesis of TRAPS
S Savic, L Ouboussad, LJ Dickie, CH Wong, R Doble, W Miriam, MF McDermott
PW02-014 - Long term outcome and quality of life in TRAPS
T Lane, A Bybee, NM Stewart, DM Rowczenio, JD Gillmore, R Al-Nackkash, H Trojer, AD Wechalekar, PN Hawkins, HJ Lachmann
PW02-015 - Eight years HPFS experience in a single UK centre
DM Rowczenio, H Trojer, G Wang, PN Hawkins, HJ Lachmann, A Baginska, T Russell, R Al-Nackkash, A Bybee
PW02-016 - 41 cases of TRAPS, a rare autoinflammatory disease
M-C Chastang, M Desjonqueres, V Hentgen, P Quartier Dit Maire, G Grateau, I Kone-Paut, B Bader-Meunier, C Wouters, I Lemelle, P Cochat
PW02-017 - New tools for the ISSAID society website
I Touitou, F Milhavet
PW02-018 - Impact of PSTPIP1 mutaions on clinical phenotype
D Holzinger, P Lohse, S Faßl, J Austermann, T Vogl, W de Jager, S Holland, M Gattorno, C Rodriguez-Gallego, J Arostegui, S Fessatou, B Isidor, K Ito, H-J Epple, J Bernstein, M Jeng, G Lionetti, P Ong, C Hinze, B Sampson, C Sunderkoetter, D Foell, J Chae, A Ombrello, J Brady, I Aksentijevich, J Roth
PW02-019 - Inflammatory pathways activation in TRAPS patients
O Negm, EM McDermott, E Drewe, R Powell, F Lucy, T Ian, P Tighe
PW02-020 - Colitis revealing mevalonate kinase deficiency
L Michael, J Camille, BM Brigitte
PW02-021 - SAA1 is the strongest predictor of AA in TRAPS
L Obici, HJ Lachmann, I Touitou, G Palladini, S Donadei, M Pasotti, L Cantarini, K Gerhold, A Meini, N Toplak, P Woo, A Martini, G Merlini, M Gattorno
PW02-022 - Recurrent fever syndromes: multiple gene mutations
M Bohm, P Dolezalova, H Lachmann, C Modesto, I Touitou, P Woo, M Finetti, V Hentgen, L Cantarini, F De Benedetti, R Gallizzi, L Obici, R Manna, E Gallo, N Ruperto, M Gattorno
PW02-023 - Qualitative aspects of autoinflammatory diseases
D Konukbay, D Yildiz, C Acikel, D Karaman, B Eren-Fidanci, Y Bilginer, I Koné-Paut, J Frenkel, M Gattorno, S Ozen, E Demirkaya
PW02-024 - A case of candle syndrome treated with thalidomide
K Yamazaki, T Miyamae, S Yokota
PW02-024-B - First report of AA amyloidosis in Blau syndrome
E Ruiz-Ortiz, A Saurina, E González-Roca, M Solé, C Modesto, F Rius, S Plaza, J Yagüe, JI Aróstegui
PW02-025 - Programme necrosis by CAPS-associated NLRP3
T Satoh, N Kambe, H Matsue
PW02-026 - Low frequency variants of NLRP3 in CAPS patients
M Lesche, A Dahl, A Kränkel, J Roesler, A Rösen-Wolff
PW02-027 - CAPS and cost-effectiveness analysis project
O Della Casa Alberighi, L Accame, J Frenkel, M Gattorno, A Martini, B Neven, P Quartier, F Pierotti, G Turchetti
PW02-028 - Association of novel NLRP3 mutations with CAPS phenotype in Turkish patients
A Berdeli, S Nalbantoglu, D Tigli, I Demirel, M Atan, B Sozeri
PW02-029 - Single cell fluorescent immunoassay of CINCA/NOMID
K Nakagawa, N Shimura, Y Shirasaki, M Yamagishi, K Izawa, R Nishikomori, T Kawai, T Yasumi, T Heike, O Ohara
PW02-030 - Clinical phenotype in individuals with Q703K
DM Rowczenio, H Trojer, G Wang, PN Hawkins, HJ Lachmann, A Baginska, T Russell, R Al-Nackkash, A Bybee, NM Stewart, T Lane
PW02-031 - Genetic and clinical manifestations of CAPS
AK Bybee, H Lachmann, E Omoyinmi, B Nedjai, P Woo, T Lane, S Savic, P Hawkins, M McDermott
PW02-032 - CNS manifestations and NLRP3/CIAS1 gene mutations
T Kümpfel, E Schuh, R Hohlfeld, P Lohse
PW02-033 - Cytokine profile in CSF in CAPS patients
E Schuh, P Lohse, M Frankenberger, I Meinl, T Kuempfel
PW02-034 - NLRP3 mosaicism detection in CAPS using NGS
M Stoffels, M Elferink, P van Zon, J Frenkel, E Hoppenreijs, A Simon, M van Gijn
PW02-035 - A role for thermo-TRP channels in innate immunity?
M Stoffels, T Remijn, LM Elders, HD de Koning, JW van der Meer, A Simon
PW02-036 - Thermosensitive CA2+ assay innate immune cells
T Remijn, M Stoffels, A Simon, JW van der Meer
PW02-037 - The Eurofever cohort of 136 patients with CAPS
R Levy, L Gerard, J Kuemmerle-Deschner, H Lachmann, I Koné-Paut, L Cantarini, P Woo, A Naselli, B Bader-Meunier, F De Benedetti, SM Al-Mayouf, S Ozen, M Hofer, J Frenkel, C Modesto, I Nikishina, A Martini, N Ruperto, B Neven, M Gattorno
PW02-038 - Treatment-resistant NOMID with autoantibodies
L Broderick, J Chang, I Szer, HM Hoffman
PW02-039 - Long-term anakinra treatment in CAPS: a metaanalys
M Leinonen, B Hallén, M Aldén-Raboisson, H Olivecrona
PW02-040 - Low-penetrance NLRP3 variants
T Endres, F Hofer, R Goldbach-Mansky, HM Hoffman, N Blank, K Krause, C Rietschel, G Horneff, P Lohse, J Kuemmerle-Deschner
PW02-041 - Canakinumab treatment regimens in CAPS-patients
F Hofer, T Endres, B Kortus-Götze, N Blank, E Weißbarth-Riedel, C Schuetz, T Kallinich, K Krause, C Rietschel, G Horneff, J Kuemmerle-Deschner
PW02-042 - Induction of MDSC in Muckle-Wells syndrome
N Rieber, A Brand, D Neri, T Hall, I Schäfer, S Hansmann, J Kümmerle-Deschner, D Hartl
OR9-001 - Exome sequencing in monogenic Behçet-like disease
Q Zhou, R Laxer, M Pelletier, M Ramaswamy, H-Y Wang, D Chin, A Gül, C Sibley, M Barat-Houari, R Siegel, DL Kastner, I Aksentijevich
OR10-001 - Altered mitochondrial ROS and metabolism in TRAPS
R Siegel, L Billingham, M pelletier, C Cudrici, A Ombrello, M Murphy, D Kastner
OR10-002 - A novel TNFR1 transcript of TRAPS gene
C Rittore, E Sanchez, S Soler, M Albers, L Obici, MF McDermott, I Touitou, S Grandemange
OR10-004 - Circulating micrornas in TRAPS
OM Lucherini, L Obici, M Ferracin, V Fulci, MF McDermott, G Merlini, I Muscari, F Magnotti, LJ Dickie, M Galeazzi, M Negrini, CT Baldari, R Cimaz, L Cantarini
OR10-005 - Treatment responses in TRAPS: Eurofever/ Eurotraps
HJ Lachmann, K Minden, L Obici, A Naselli, A Insalaco, V Hentgen, R Merino, C Modesto, N Toplak, R Berendes, R Cimaz, A Jansson, A Martini, P Woo, I Touitou, M Gattorno
OR10-006 - Canakinumab in patients with TRAPS
HJ Lachmann, L Obici, A Meini, V Tormey, K Abrams, N Davis, C Andrews, SG Bhansali, M Gattorno
OR11-001 - Protein misfolding in mevalonate kinase deficiency
S Stojanov, SW Gersting, L Reitzle, D Reiß, BH Belohradsky, M Vogeser, B Maier, D Teupser, AC Muntau
OR11-002 - Mutations in MVK cause non-syndromic RP
AM Siemiatkowska, M Stoffels, K Neveling, A Simon, PM van Hagen, AI den Hollander, FP Cremers, LI van den Born, RW Collin
OR11-003 - The NLRP3 inflammasome is regulated by CaSR
JJ Chae, G-S Lee, N Subramanian, DL Kastner
OR11-004 - IL-1, IL-18 and cell death in NLRP3 driven disease
L Broderick, SD Brydges, MD McGeough, CA Pena, JL Mueller, HM Hoffman
OR11-005 - Mast cells respond to pathogen signals with IL-1ß
L Kraas, O Schmetzer, K Krause, E Latz, M Maurer
OR11-006 - A mutation in NLRP1A causes autoinflammation
SL Masters, M Gerlic, BT Kile, BA Croker
P03-001 - PFAPA and MEFV genes
F Salehzadeh, M Vahedi, S Jahangiri, S Hosseiniasl
P03-002 - Different phenotypes associated with Q703K variant
A von Scheven-Gête, I Moix, G Simon, N Busso, M Morris, M Hofer
P03-003 - Sacroilitis with propionibacterium acnes
C Galeotti, I Koné-Paut
P03-004 - Production of proinflammatory cytokines in PFAPA
A Kozlova, O Barabanova, N Davydova, A Shcherbina
P03-005 - MEFV heterozygous mutations in PFAPA patients
A Kozlova, O Barabanova, N Kuzmenko, N Zinovieva, O Molochnikova, A Shcherbina
P03-006 - Pamidronate rapidly decreases CRP and TNFΑ in CNO
MM Kostik, LI Vasyakina, VM Ponomarenko, IA Chikova, AV Minkin, OV Kalashnikova, IV Shvedovchenko, VG Chasnyk
P03-007 - Mevalonate kinase gene in Behçet’s disease
D Arslan Tas, E Erken, F Yıldız, S Dinkçi, H Sakallı
P03-008 - Gastrointestinal involvement in Behçet’s syndrome
I Hatemi, G Hatemi, Y Erzin, AF Celik, H Yazici
P03-009 - Experiences of in pediatric Behçet uveitis
B Sozeri, S Yilmaz, S Mir, H Ates
P03-010 - IL10 SNPs associated with BD in Western Algeria
O Khaib Dit Naib, M Aribi, A Idder, A Chiali, H Sairi, I Touitou, G Lefranc, M Barat-Houari
P03-010-B - A novel mutation in MEFV gene is not enough
D Martorana, M Carrabba, G Fabio
P03-011 - Differential for granulomatosis with polyangiitis
SM Rawn, P Miettunen, H Schmeling
P03-012 - A P268S NOD2 mutation in one Blau patient
M Pardeo, E Cortis, C Bracaglia, R Nicolai, F De Benedetti, A Insalaco
P03-012-B - Lupus erythematous chronicus: a new etiology of macrocheilitis
M Mael-Ainin, H Boudhir, A Saidi, B Hassam, K Senouci
P03-013 - Symptomatic neuromuscular sarcoidosis
M Mulazzani, C Haberler, F Zimprich, EV Hartl, H Cetin
P03-013-B - Inaugural palate nodule of a systemic sarcoidosis
M Mael-Ainin, M Bouaddi, K El Morabite, S Abil, A Abdou, K Senouci, B Hassam, I El Meknassi
P03-014 - Biological therapy for autoinflammatory disorders
S Bujan Rivas, JI Arostegui Gorospe, F Martinez Valle, R Solans laque, JF Andres Cordon, J Ordi Ros, M Vilardell Tarres
P03-015 - Dapson treats chronic Pupura Schoenlein (PSH)
G Dueckers, M Frosch, C Assaf, H Wiggermann, D Schneider, T Niehues
P03-016 - ANTI IL1 refractory CINCA respondes to ANTI IL6
G Dueckers, K Sinha, V Soditt, G Ganser, T Niehues
P03-017 - Health related quality of life in adult with HRFS
HJ Lachmann, N Stewart, T Lane, DM Rowczenio, PN Hawkins
P03-018 - Diversity in presenting manifestations of AUTOINFL
S Boiu, B Neven, S Compeyrot-Lacassagne, R Mouy, C Wouters, B Bader-Meunier, M Gattorno, P Quartier
P03-019 - Anakinra for sweet syndrome treatment
G Passaro, L Cerrito, M Giovinale, A Marinaro, A Soriano, D Rigante, R Manna
P03-020 - A novel 15-HPGD mutation in pachydermoperiostosis
E Erken, Ç Köroğlu, F Yıldız, HT Özer, B Gülek, A Tolun
P03-021 - Characterization of BM-MSC from osteopetrotic mice
F Schena, E Caci, N Lo Iacono, V Marrella, M Gattorno, A Martini, C Sobacchi, A Villa, E Traggiai
P03-023 – Autoinflammatory diseases database in Japan
T Kawai, R Nishikomori, M Awaya, K Nakagawa, K Izawa, T Yasumi, O Ohara, T Heike
P03-024 – Early onset IBD treated by tocilizumab
R Helbling, A Nyddeger, F Angelini, A Von Scheven Gete, M Hofer
P03-025 – Differential diagnosis of autoimmune disorders
A Kozlova, N Zinovieva, J Bustamante, S Boisson-Dupuis, J-L Casanova, A Shcherbina
P03-026 – Sweet’s syndrome: report of a new case
M Mael-Ainin, H Boudhir, A Saidi, K Senouci, B Hassam
P03-027 - A brief Case report on specific undiagnosed condition, whose provisional diagnosis on the basis of provisional lab investigation proved as one of the component of autoinflammatory disorder
S Sathyanandan, LK Md
P03-028 – Spectacular efficiency of isotretinoin in small doses in the sebopsoriasis treatment
M Mael-Ainin, H Boudhir, A Saidi, K Senouci, B Hassam
PW03-001 - PFAPA syndrome in Turkish children
ED Batu, F Kara Eroglu, Y Bilginer, S Ozen
PW03-002 – Calculating Gaslini diagnostic score in PFAPA
I Bosio, A Meini, P Cancarini, G Savoldi, M Berlucchi, M Cattalini
PW03-003 – Altered neutrophil function in PFAPA
M Sundqvist, P Wekell, V Osla, J Bylund, K Christensson, K Sävman, A Fasth, S Berg, KL Brown, A Karlsson
PW03-004 - PFAPA patient’s serum sensitizes monocytes to LPS
G Simon, N Busso, A von Scheven-Gete, A So, M Hofer
PW03-005 - NLRP3-Q705K monocytes do not produce more IL-1B
G Simon, N Busso, A von Scheven-Gete, I Moix, M Morris, A So, M Hofer
PW03-006 - IL-1-B inhibition in Schnitzler’s syndrome
HD De Koning, J Schalkwijk, J Jongekrijg, M Stoffels, JW van der Meer, A Simon
PW03-007 - NLRP3 genetic variants in Schnitzler’s syndrome
HD De Koning, J Schalkwijk, JW van der Meer, PL Zeeuwen, K Neveling, M van Gijn, A Simon
PW03-008 – Mitochondrial disturbances in Schnitzler syndrome
A Sediva, H Hansikova, J Sladkova, M Rodinova, Z Hajkova, J Zeman, P Szturz
PW03-009 – Genetics of PFAPA syndrome
L Broderick, D Carvalho, A Magit, W Jiang, S Leuin, M Bothwell, D Kearns, S Pransky, HM Hoffman
PW03-010 - MHC complexity in Behçet's disease
MJ Ombrello, Y Kirino, P de Bakker, F Cosan, DL Kastner, A Gul, EF Remmers
PW03-011 – New Behçet's loci and gene-gene interactions
EF Remmers, Y Kirino, G Bertsias, MJ Ombrello, G Wood, Y Ishigatsubo, N Mizuki, I Tugal-Tutkun, E Seyahi, Y Ozyazgan, DL Kastner, A Gül
PW03-012 – Unmet need in Behçet's disease: remission is rare
F Alibaz-Oner, G Mumcu, Z Kubilay, G Ozen, G Celik, A Karadeniz, M Can, S Yılmaz Oner, N Inanc, P Atagündüz, H Direskeneli
PW03-013 - Behçet's disease: genotype-phenotype correlations
M Takeuchi, T Kawagoe, A Meguro, Y Ishigatsubo, E Remmers, D Kastner, N Mizuki
PW03-014 - TLR4 and MEFV variants are Behçet's risk factors
Y Kirino, Q Zhou, Y Ishigatsubo, N Mizuki, Y Kim, DL Kastner, A Gül, EF Remmers
PW03-014B - Gene-expression profiling study in FMF families
B Aygun, M Carrabba, M Fabbri, L Gribaldo, M Zarantonello, G Fabio
PW03-016 – Blau prospective cohort study: articular outcomes
CD Rose, R Cimaz, C Thomee, R Khubchandani, G Espada, R Russo, M Harjacek, B Bader-Meunier, P Brissaud, N Wulffraat, S Vastert, R Merino, A Naranjo-Hernandez, S Oliveira-Knupp, F Mackensen, J Arostegui, J Anton, J Fernandez-Martin, C Wouters
PW03-017 – Combination TNF and IL-1 blockade in PAPA syndrome
P Hoffmann, AK Ombrello, DL Stone, KS Barron, DL Kastner
PW03-018 – Efficacy of Anakinra in recurrent pericarditis
M Finetti, A Insalaco, L Cantarini, M D'Alessandro, A Meini, L Breda, M Alessio, P Picco, A Martini, M Gattorno
PW03-019 – Survey of off-label ANTI-IL1 treatments in France
L Rossi-Semerano, B Fautrel, D Wendling, E Hachulla, A Meyer, S Ottaviani, C Galeotti, M Fouillet-Desjonqueres, O Richer, I Touitou, I Koné-Paut
PW03-020 – A decade of ANTI-IL-1 therpay for CAPS in the UK
T Lane, NM Stewart, A Bybee, DM Rowczenio, K Wynne, H Trojer, A Baginska, PA Brogan, PN Hawkins, HJ Lachmann
PW03-021 - HSCT in mevalonate kinase deficiency
B Wolska-Kuśnierz, B Mikołuć, R Motkowski, K Kałwak, E Bernatowska, D Rowczenio
PW03-022 – Neutrophilic skin disease and inflammation
K Webb, C Hlela, C Scott
PW03-023 – Role of S100A4 in inflammatory disorders
M Grigorian, MT Hansen, B Forst, D Sevumian, J Klingelhofer, H Hayrapetyan, T Sarkisian, N Ambartsumian
PW03-024 - A transgenic mouse model for variant procaspase-1
A Hermsdorf, F Pessler, H Luksch, S Winkler, R Naumann, J Roesler, A Roers, A Rösen-Wolff
PW03-025 - Procaspase-1 contributes to inflammation via NF-KB
M Heymann, S Winkler, S Özen, E Yilmaz, T Kallinich, A Rösen-Wolff, J Roesler, S Hofmann
PW03-026 - Caspase-1 variants involved in ER stress
H Luksch, V Schlipfenbacher, S Winkler, J Roesler, A Rösen-Wolff
PW03-027 - CASP1 variants and live cell imaging
S Rabe, MC Heymann, S Russ, S Winkler, J Roesler, A Rösen-Wolff, SR Hofmann
PW03-028 – Atypical presentation of CRMO in two children
F Vanoni, A Von Scheven-Gête, M Hofer
PW03-029 – Risk factors for AA-type amyloidosis in Germany
N Blank, P Lohse, U Hegenbart, H-M Lorenz, SO Schoenland
PW03-030 – Collecting patients data to inform genetic studies
AK Bybee, F Aslam, E Majdoub, D Rowczenio, A Baginkska, R Al-Nackkash, W Taylor, P Hawkins, H Lachmann
PW03-031 – Activation-induced cell death of human monocytes
M Miranda-Garcia, J Daebritz, G Varga, T Weinhage, J Ehrchen, K Barczyk, J Roth, D Foell
PW03-032 – Periodic fevers in children
C Harper, C Corlett, G Macdonald, G Worthington, D Porter, D Kelly, S Segal, AJ Pollard, S Atkinson
PW03-033 - SLC29A3 mutation: a new autoinflammatory condition
I Melki, K Lambot, L Jonard, V Couloigner, P Quartier, B Neven, B Bader-Meunier
PW03-034 – How to classify autoinflammatory diseases?
G Grateau, V Hentgen, K Stankovic, I Jéru, S Amselem, O Steichen
PW03-035 – Autoinflammatory diseases diagnostic chart/tool
KL Durrant, I Muscari, JI Aróstegui
PW03-036 – Neutrophilic urticaria with systemic inflammation
H Belani, K Leslie
OR13-001 Loss-of-function mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause recurrent fevers and early onset strokes
Q Zhou, A Zavialov, J Chae, M Hershfield, R Sood, S Burgess, A Zavialov, D Chin, M Gadina, R Goldbach-Mansky, A Ombrello, D Stone, I Aksentijevich, D Kastner
OR13-002 Recessive mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause systemic and cutaneous polyarteritis nodosa (PAN)
E Levy-Lahad, P Elkan-Navon, R Segel, SB Pierce, T Walsh, J Barash, S Padeh, A Zlotogorski, YY Berkun, JJ Press, M Mukamel, PJ Hashkes, LL Harel, M Tekin, F Yalcinkaya, O Kasapcopur, EF Emirogullari, MK Lee, RE Klevit, PF Renbaum, A Weinberg-Shukron, S Zeligson, D Marek-Yagel, M Shohat, A Singer, E Pras, AA Rubinow, Y Anikster, M-C King
OR13-003 - TNFRSF11A molecular defects cause autoinflammatory disorders
I Jéru, E Cochet, P Duquesnoy, V Hentgen, B Copin, M Mitjavila-Garcia, S Sheykholeslami, G Le Borgne, F Dastot, S Karabina, M Mahevas, S Chantot-Bastaraud, L Faivre, S Amselem
OR13-004 – Evidence-based clinical classification criteria for periodic fevers
S Federici, S Ozen, I Koné-Paut, H Lachmann, P Woo, L Cantarini, G Amaryan, A Insalaco, J Kuemmerle-Deschner, B Neven, N Dewarrat, Y Uziel, D Rigante, T Herlin, S Martino, A Simon, S Stojanov, H Ozdogan, J Frenkel, N Ruperto, A Martini, M Sormani, M Hofer, M Gattorno
OR13-005 – Investigation of clinical and laboratory significance of TNFRSF1A intron by reverse-phase protein microarray
E Drewe, O Negm, W Abduljabbar, P Hawkins, L Fairclough, I Todd, P Tighe
OR14-001 – Tocilizumab in autoinflammation and AA amyloidosis
T Lane, JD Gillmore, AD Wechalekar, NM Stewart, JA Gilbertson, S Sachchithanantham, DM Rowczenio, S Banypersad, JH Pinney, S Mahmood, HJ Lachmann, PN Hawkins
OR14-002 - ANTI IL-1 therapies and pregnancy outcome
HJ Lachmann, H Ozdogan, A Simon, N Stewart, DM Rowczenio, S Ugurlu, T Lane, PN Hawkins